Monday, February 21, 2011

Neuronal Activity Controls the Antagonistic Balance Between Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α and Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptors in Regulating Antioxidant Defenses

›
Antioxidants & Redox Signaling (14, 000–000). -Online Ahead of Print: February 20, 2011-. doi:10.1089/ars.2010.3568. Francesc X. Soria...
Saturday, February 19, 2011

Transition to adult care for children with chronic neurological disorders

›
Annals of Neurology, 2011, DOI: 10.1002/ana.22393 Peter Camfield MD, Carol Camfield MD "We make a series of suggestions about how ...
Friday, February 18, 2011

Quantification of Circulating Plasma DNA in Friedreich's Ataxia and Spinocerebellar Ataxia Types 2 and 12

›
DNA and Cell Biology. null, Vol. 0, No. 0, Online Ahead of Print: February 17, 2011. doi:10.1089/dna.2010.1165. Vishnu Swarup, Achal K. Sr...
Friday, February 11, 2011

Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics

›
Journal of the Neurological Sciences, doi:10.1016/j.jns.2011.01.010 Arnulf H. Koeppen VA Medical Center, 113 Holland Ave, and Albany Med...
Tuesday, February 8, 2011

Gene therapy finds its niche

›
Nature Biotechnology Volume: 29, Pages: 121–128 Year published:(2011) doi:10.1038/nbt.1769 Cormac Sheridan Gene therapy is finally pois...

ReNeuron and StemCells get green light for neural stem cell trials

›
Nature Biotechnology Volume: 29,Pages: 95–97 Year published:(2011) doi:10.1038/nbt0211-95 George S Mack Maybe not as fast as we would li...
Thursday, February 3, 2011

Gene Therapy Moves Forward in 2010

›
Molecular Therapy (2011) 19 2, 219–220. doi:10.1038/mt.2010.307 Seppo Ylä-Herttuala Deputy Editor, and President (2011–2012), European So...
Wednesday, February 2, 2011

(WO/2011/009890) USE OF AZABICYCLOALKYL DERIVATIVES OR PYRROLIDINE-2-ONE DERIVATIVES

›
Patent WO/2011/009890, 27.01.2011, Aplicants: NOVARTIS AG [CH/CH]; FEUERBACH, Dominik [DE/CH]; GOMEZ-MANCILLA, Baltazar [MX/CH]. The inv...

"Proof of principle", Gene therapy by allele selection in a mouse model of beta-thalassemia

›
J Clin Invest. 2011;121(2):623–627. doi:10.1172/JCI45377.(February 1, 2011). Sigrid Eckardt1, N. Adrian Leu2, Ashley Yanchik2, Seigo Ha...
Tuesday, February 1, 2011

Johns Hopkins Researchers Develop Safer Way To Make Induced Pluripotent Stem Cells

›
Stem Cell Research News From Medical News Today, Article Date: 01 Feb 2011 - 4:00 PST Researchers at Johns Hopkins have found a better way...